Arterys said today that it raised a $12 million Series A round for the MR-based vascular imaging system it’s developing. The San Francisco-based company said its system uses data from a 10-minute MRI chest scan to compute blood flow information with “deep learning” and artificial intelligence technology. Available to researchers now, the system is expected […]
Venture Capital/Private Equity
Becton Dickinson deals controlling half of respiratory business to Apax Partners
Becton Dickinson & Co. (NYSE:BDX) said today that it inked a deal to sell a 50.1% stake in its respiratory business to private equity giant Apax Partners for an undisclosed amount, forming a joint venture to operate the unit as a stand-alone company. The new entity will take BD’s ventilation, respiratory diagnostics, vital signs and AirLife businesses on […]
UPDATE: Zipline raises $19m for Zip surgical closure tech
ZipLine Medical, which last week reported a more than $16 million funding round in a regulatory filing, said today that it pulled in $19 million for its Zip surgical wound closure technology, led by new backer MVM Life Science Partners and including existing investor China Materialia. “This financing allows us to further expand our global sales and marketing activities leveraging the […]
BiO2 Medical drums up $9m Series D for Angel catheter
BiO2 Medical said yesterday that it raised a $9 million Series D round for its Angel catheter, after concluding its pivotal clinical trial a year ahead of schedule. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San […]
Bosch gets in on $3m Series B for Emperra’s ‘smart’ diabetes system
Emperra said today that it closed a Series B round worth $3.1 million for its Esysta “smart” diabetes management system. Potsdam, Germany-based Emperra said the VC arm of the Bosch Group, Robert Bosch Venture Capital, joined existing backers Peppermint VenturePartners and Investitionsbank des Landes Brandenburg. CEO Christian Krey and CTO Dr. Janko Schildt also got in on the round, Emperra said. Esysta, which […]
OrbiMed launches $950m healthcare fund
OrbiMed said it closed another venture capital fund worth $950 million that it plans to deploy on about 30 companies in the medical device, biopharmaceutical, diagnostics and healthcare IT markets. The New York-based VC giant said its OrbiMed Private Investments VI fund will put up investments ranging from $10 million to $75 million. Last year OrbiMed floated a $924 […]
Diabetes: Fractyl Labs closes $57m Series C round
Fractyl Laboratories said today that it closed a Series C round worth $57 million with a final, $17 million tranche joined by new backer Deerfield Management, as it readies its Retiva device for a Phase II trial. Waltham, Mass.-based Fractyl calls the Retiva a “duodenal mucosal resurfacing” device; it’s designed to separate the mucosa and sub-mucosa […]
Private equity giant KKR puts $35m into Signostics
Signostics said it landed $35 million from private equity giant KKR (NYSE:KKR) for its handheld ultrasound technology. “KKR offers us the privilege of working with a highly regarded long-term capital partner which will enable us to create next-level innovations and beyond, aimed at greater disruption and democratization of the global ultrasound market,” CEO Kevin Goodwin, who […]
Medtronic, Sequoia Capital launch $60m China fund
Medtronic (NYSE:MDT) and venture capital firm Sequoia Capital reportedly launched a $60 million fund for medical technology investments in China. The fund aims to back both Chinese startups with the legs for global markets and companies outside China with products that could succeed there, according to the China Money Network. Suzhou-BioBay, a life sciences incubator, also […]
VC fund adds PricewaterhouseCoopers to $17m embezzlement suit against founder Burrill
The investors behind a venture capital fund added accounting firm PricewaterhouseCoopers to a lawsuit alleging that the fund’s founder, biotech notable Stephen Burrill, and other fund executives looted it for $17 million. The Burrill Life Sciences Capital Fund III 1st sued last July, accusing Burrill, longtime outside-counsel-turned-staff-counsel Victor Hebert and CFO Helena Sen of diverting the cash […]
Taris reboots with $32m round for bladder tech
A year after dealing its Liris bladder treatment to Allergan in a deal worth up to $588 million, Taris Biomedical raised another $32 million to put toward the implant, which is designed to deliver drugs directly to the bladder. Allergan paid $67.5 million in cash in August 2014 for Liris, a drug-device combination designed to deliver lidocaine to treat […]